We have collected information about Small-Molecule Delivery By Nanoparticles For Anticancer Therapy for you. Follow the links to find out details on Small-Molecule Delivery By Nanoparticles For Anticancer Therapy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729441/
Using nanoparticles for the delivery of small molecules in anticancer therapy is a rapidly growing area of research. The advantages of using nanoparticles for drug delivery include enhanced water solubility, tumor-specific accumulation and improved antitumor efficacy, while reducing nonspecific toxicity.Author: Zhuo (Georgia) Chen
https://www.sciencedirect.com/science/article/pii/S1471491410001139
Using nanoparticles for the delivery of small molecules in anticancer therapy is a rapidly growing area of research. The advantages of using nanoparticles for drug delivery include enhanced water solubility, tumor-specific accumulation and improved antitumor efficacy, while reducing nonspecific toxicity.Author: Zhuo (Georgia) Chen
https://www.cell.com/trends/molecular-medicine/pdf/S1471-4914(10)00113-9.pdf
Small-molecule delivery by nanoparticles for anticancer therapy Zhuo (Georgia) Chen Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA, USA Usingnanoparticlesforthedeliveryofsmallmoleculesin anticancer therapy is a rapidly growing area of research.
https://www.researchgate.net/publication/46288079_Small-molecule_delivery_by_nanoparticles_for_anticancer_therapy
Using nanoparticles for the delivery of small molecules in anticancer therapy is a rapidly growing area of research. The advantages of using nanoparticles for drug delivery include enhanced water...
https://advances.sciencemag.org/content/6/14/eaaz9798.full
10 days ago · BEZ235 is an effective dual PI3K/mTOR inhibitor, but it was withdrawn from early-phase clinical trials owing to poor solubility and on-target/off-tumor toxicity. Here, we developed a nanoparticle (NP)–based pretargeted system for the therapeutic delivery of BEZ235 to CD20- and HLA-DR–expressing lymphoma cells for targeted therapy.
https://www.researchgate.net/profile/Rajendra_Singh9/publication/280221716_Smart_multifunctional_drug_delivery_towards_anticancer_therapy_harmonized_in_mesoporous_nanoparticles/links/55b6b9b208ae9289a08bc076/Smart-multifunctional-drug-delivery-towards-anticancer-therapy-harmonized-in-mesoporous-nanoparticles.pdf
intravenous delivery, which is preferred administration route for many anticancer drugs. Furthermore, nanomaterials may enhance the drug uptake by specific cells, thus achieve the same therapeutic
Searching for Small-Molecule Delivery By Nanoparticles For Anticancer Therapy?
You can just click the links above. The data is collected for you.
